Searched for
NETANYAHU PROSTATE CANCER TREATMENT
Israeli defence minister says 'no US demand' to withdraw from LebanonIsrael's Defence Minister Israel Katz stated that the US has not demanded a troop withdrawal from southern Lebanon, a key Lebanese conditio...- Cancer ♋ July 2026 Horoscope, Monthly Predictions: Major Opportunities and Unexpected Breakthroughs Await After Mid-Month♋ Cancer Monthly Horoscope (1st July 2026 to 31st July 2026): Your Cancer Monthly Horoscope can bring a blend of introspection and fresh be...
- Israel smuggled Starlink systems into Iran, former PM saysFormer Israeli Prime Minister Naftali Bennett revealed he initiated smuggling Starlink receivers into Iran to aid anti-government protester...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Poll finds Israelis believe Iran won Mideast warThe poll of 3,644 respondents, conducted between June 17 and 20 by the Hebrew University of Jerusalem in collaboration with the Agam Instit...
- Doctors find new non-surgical treatment for osteoarthritis patients that may relieve knee pain in weeksA groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...
- Weekly Horoscope for ♋ CANCER (June 20 - June 26, 2026): A Powerful New Chapter Begins as Confidence and Clarity ReturnCancer Weekly Horoscope (20th June 2026 to 26th June 2026): Cancer, this week marks the beginning of a powerful personal cycle as the Sun e...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- Jeremy Clarkson cancer: The ‘aggressive’ diagnosis he caught early and the symptoms men shouldn’t ignoreJeremy Clarkson has revealed his diagnosis with an aggressive form of prostate cancer, detected last summer and treated with surgery. Prost...
- Benjamin Netanyahu, Israel's arch-survivor, set to face voter fury over Iran dealBenjamin Netanyahu's grip on power is weakening. Facing corruption charges and criticism over security lapses, he now confronts voters' jud...
- Trump goes after Netanyahu as he pursues deal with Iran, putting their friendship to the testFormer US President Donald Trump has publicly criticized Israeli Prime Minister Benjamin Netanyahu. Trump claims credit for Israel's existe...
- Netanyahu and Trump on collision course as US, Iran agree to halt warIsrael's Prime Minister Benjamin Netanyahu faces a clash with U.S. President Donald Trump over a new interim deal with Iran. Israel feels t...
- Novartis India launches Pluvicto for prostate cancer treatmentNovartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
Load More
